Total Holdings
25
As of Oct 4, 2026
Roundhill GLP-1 & Weight Loss ETF
OZEMNASDAQRoundhillEquity
$29.25Today:- (-)1Y +6.27%
As of Oct 16, 2026 close
- Assets (AUM)
- $56.64M
- Expense ratio
- 0.59%
- Dividend yield
- 1.39%
- Holdings
- 25
- 52-week range
- $27.34$37.15
- Volume (live)
- -
- Avg. volume (3M)
- 15.43K
OZEM ETF Holdings: Roundhill GLP-1 & Weight Loss ETF
Every listed position with its portfolio weight, plus sector breakdown and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Top 10 Holdings
67.6%
Share of fund assets
Assets (AUM)
$56.64M
Total fund assets
Expense Ratio
0.59%
Annual management fee
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
All 27 OZEM Holdings by Portfolio Weight
Holdings as of Oct 4, 2026. Ticker, name, asset type and portfolio weight for each position.
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Eli Lilly and Company | Stock | 12.90% |
| 2 |  | Novo Nordisk A/S | Stock | 12.05% |
| 3 |  | Pfizer Inc. | Stock | 7.72% |
| 4 | HKG:1093 | CSPC Pharmaceutical Group Limited | Stock | 6.91% |
| 5 |  | Viking Therapeutics, Inc. | Stock | 5.17% |
| 6 |  | Kailera Therapeutics, Inc. | Stock | 4.84% |
| 7 | 4519.JP | Chugai Pharmaceutical Co Ltd | Stock | 4.61% |
| 8 | KRX:128940 | Hanmi Pharm. Co., Ltd. | Stock | 4.53% |
| 9 |  | Amgen Inc | Stock | 4.49% |
| 10 | HKG:1672 | Ascletis Pharma Inc. | Stock | 4.39% |
| 11 | TSE:4519 | Chugai Pharmaceutical Co. Ltd. | Stock | 4.12% |
| 12 | CO:ZEAL | Zealand Pharma A/S | Stock | 4.06% |
| 13 | ZEAL.DC | Zealand Pharma A/S | Stock | 3.95% |
| 14 | LON:AZN | AstraZeneca PLC | Stock | 3.78% |
| 15 | SWX:ROP | Roche Holding AG | Stock | 3.19% |
| 16 | HKG:1276 | Jiangsu Hengrui Pharmaceuticals Co.,Ltd | Stock | 2.96% |
| 17 | HKG:3933 | The United Laboratories International Holdings Limited | Stock | 2.85% |
| 18 | HKG:3692 | Hansoh Pharmaceutical Group Company Limited | Stock | 2.83% |
| 19 | HKG:1801 | Innovent Biologics, Inc. | Stock | 2.50% |
| 20 |  | Structure Therapeutics Inc. | Stock | 2.25% |
| 21 | GUBRA.DC | Gubra A/S | Stock | 2.21% |
| 22 |  | MBX Biosciences, Inc. | Stock | 2.14% |
| 23 |  | Gilead Sciences, Inc. | Stock | 1.84% |
| 24 |  | Rhythm Pharmaceuticals, Inc. | Stock | 1.47% |
| 25 | 4507.JP | Shionogi & Co Ltd | Stock | 1.32% |
| 26 |  | Wave Life Sciences, Inc. | Stock | 0.30% |
| 27 | CHF | SWISS FRANC | Stock | 0.00% |
Source: Fund holdings disclosures. Data as of Oct 4, 2026. Data sources and methodology
Frequently Asked Questions About Roundhill GLP-1 & Weight Loss ETF Holdings
What are the top holdings in OZEM?
As of Oct 4, 2026, Roundhill GLP-1 & Weight Loss ETF (OZEM) holds 25 securities. The largest are Eli Lilly and Company (12.90%), Novo Nordisk A/S (12.05%), Pfizer Inc. (7.72%). The holdings table lists each position by portfolio weight with its ticker, name and asset type.
How concentrated is OZEM's portfolio?
As of Oct 4, 2026, the 10 largest positions make up 67.6% of OZEM's assets. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly.
What is OZEM's sector allocation?
The Sector Allocation chart shows how OZEM distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does OZEM invest in?
OZEM's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is OZEM ETF?
OZEM's diversification can be assessed by reviewing its 25 holdings (as of Oct 4, 2026), sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.